4th Quarter - Report

WILLIAMS AND JENSEN, PLLC for NOVO NORDISK INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Medication affordability and access; general diabetes prevention, 340B, monitoring FDA reform, changes and new programs.

LobbyistCovered position, as disclosed
ROBERT BUTORA Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess
JEANNE HAGGERTY Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
MELINDA M MAXFIELD —
KURT SCHRADER Former Member of Congress
CHRISTOPHER E. WILCOX LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Support for obesity drug coverage and access.

LobbyistCovered position, as disclosed
ROBERT BUTORA Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess
JEANNE HAGGERTY Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
MELINDA M MAXFIELD —
KURT SCHRADER Former Member of Congress
CHRISTOPHER E. WILCOX LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Treat and Reduce Obesity Act; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169) implementation. Pharmacy benefit manager reform proposals. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.

LobbyistCovered position, as disclosed
ROBERT BUTORA Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess
JEANNE HAGGERTY Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
MELINDA M MAXFIELD —
CHRISTOPHER E. WILCOX LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (119th)

Taxation/Internal Revenue Code TAX

Issues related to corporate tax and international tax including related domestic and international tax issues for reconciliation legislation; monitor implementation of PL 119-21.

LobbyistCovered position, as disclosed
JEANNE HAGGERTY Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
CHRISTOPHER W HATCHER —
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

General issues related to patent protections.

LobbyistCovered position, as disclosed
JEANNE HAGGERTY Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
CHRISTOPHER E. WILCOX LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.